These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 669801)

  • 1. Cross-protection of mice provided by active and passive immunization against experimental infections with virulent Proteus rettgeri and Providencia bacteria.
    Penner JL; Whiteley GR
    Infect Immun; 1978 May; 20(2):347-51. PubMed ID: 669801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of a Providencia rettgeri strain that has enterobacterial common antigen in the immunogenic state.
    Quigley RC; Penner JL
    Can J Microbiol; 1987 Dec; 33(12):1055-63. PubMed ID: 3328641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccination against Porteus mirabilis.
    Jones RJ
    Br J Exp Pathol; 1976 Aug; 57(4):395-9. PubMed ID: 822863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against experimental Proteus mirabilis pyelonephritis in rats and significance of immunity.
    Larsson P; Kaijser B; Olling S; Akerlund AS
    Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):215-20. PubMed ID: 31056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The anodically moving thermolabile antigen (ATA) of Gram negative bacteria. Protection of mice by immunization with ATA (author's transl)].
    Seltmann G; Reissbrodt R
    Acta Microbiol Acad Sci Hung; 1979; 26(1):55-62. PubMed ID: 384750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of O-serotyping in a study of Providencia rettgeri (Proteus rettgeri) isolated from human and nonhuman sources.
    Penner JL; Hennessy JN
    J Clin Microbiol; 1979 Dec; 10(6):834-40. PubMed ID: 521481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in urease activity of endemic hospital strains of Proteus rettgeri and Providencia stuartii.
    Penner JL; Hinton NA; Whiteley GR; Hennessy JN
    J Infect Dis; 1976 Oct; 134(4):370-6. PubMed ID: 789790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anodically moving thermolabile antigen (ATA) of Gram-negative bacteria. Its antibody-forming capacity in rabbits and mice].
    Reissbrodt R; Eichstädt M; Seltmann G
    Z Allg Mikrobiol; 1979; 19(1):53-5. PubMed ID: 312565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenic characteristics of standard strains of Providencia rettgeri (O- and H-antigens)].
    Romanenko EE; Raginskaia VP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):31-5. PubMed ID: 2416153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationships between O-antigens of Providencia and Rettgerella].
    Raginskaia VP; Levina LA; Romanenko EE; Kholodkova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):85-9. PubMed ID: 6171959
    [No Abstract]   [Full Text] [Related]  

  • 11. Reconstitution of the somatic (O-) antigenic scheme for Providencia and preparation of O-typing antisera.
    Penner JL; Hinton NA; Hennessy JN; Whiteley GR
    J Infect Dis; 1976 Mar; 133(3):283-92. PubMed ID: 56410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of immunization with Proteus vaccine on the donor organism].
    Zdanovskaia LK
    Gematol Transfuziol; 1990 Apr; 35(4):35-8. PubMed ID: 2373348
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection.
    Harmon RC; Rutherford RL; Wu HM; Collins MS
    Infect Immun; 1989 Jul; 57(7):1936-41. PubMed ID: 2659528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of Proteus, Morganella and Providencia strains isolated from patients with urinary tract infections on bactericidal activity of normal human serum].
    Jankowski S; Krzyzanowska B; Lachowicz TM; Doroszkiewicz W; Mokracka-Latajka G
    Med Dosw Mikrobiol; 1993; 45(3):301-5. PubMed ID: 8189801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Active and passive immune therapy of surgical Proteus infection].
    Kreĭnin LS
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):19-25. PubMed ID: 3898658
    [No Abstract]   [Full Text] [Related]  

  • 16. Host defenses in experimental scrub typhus: role of cellular immunity in heterologous protection.
    Shirai A; Catanzaro PJ; Phillips SM; Osterman JV
    Infect Immun; 1976 Jul; 14(1):39-46. PubMed ID: 820646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity].
    Zaĭtsev EV; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):74-8. PubMed ID: 2251896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Proteus rettgeri O-serotyping system for epidemiological investigation.
    Penner JL; Hinton NA; Hennessy JN
    J Clin Microbiol; 1976 Apr; 3(4):385-9. PubMed ID: 57120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological characterization of the core region of lipopolysaccharides of rough Proteus sp. strains.
    Palusiak A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):303-10. PubMed ID: 19578814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective properties of antigenic complexes of Proteus].
    Kreĭnin LS; Kaverina KG; Aksenova EV; Buatkova LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):60-4. PubMed ID: 7015763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.